Associate Professor Janette Vardy

Principal Research Fellow
Medicine, Concord Clinical School

C22 - Concord Hospital
The University of Sydney
NSW 2006 Australia

T: 9767 5000

On this page

Themes | Grants | Keywords | Publications


Current national competitive grants*


Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial
Vardy J, Dhillon H, Bell M, Cysique L, Boyle F, Clarke S
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($600,000 over 3 years)


Phase III Study of the impact of a physical activity program on disease-free survival for early colon cancer
Vardy J, Dhillon H, Van Der Ploeg H, Zalcberg J, Courneya K, Meyer R
NHMRC Project Grants ($2,418,375 over 6 years)

* Grants administered through the University of Sydney


Behavioural neuroscience; Breast cancer; Lung cancer; Cancer; Bowel cancer


2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Kao, S., van Zandwijk, N., Clarke, S., Vardy, J., Lumba, S., Tognela, A., Ng, W. (2015), Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care. Asia-Pacific Journal of Clinical Oncology. 11, 85-92. [Abstract]
  • Ma, L., Ai, P., Li, H., Vardy, J. (2015), The prophylactic use of Chinese herbal medicine for chemotherapy-induced leucopenia in oncology patients: a systematic review and meta-analysis of randomized clinical trials. Supportive Care in Cancer. 23(2), 561-579. [Abstract]


  • Fardell, J., Zhang, J., De Souza, R., Vardy, J., Johnston, I., Allen, C., Henderson, J., Piquette-Miller, M. (2014), The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice. Psychopharmacology. 231(5), 841-852. [Abstract]
  • Vardy, J., Dhillon, H., Pond, G., Rourke, S., Xu, W., Dodd, A., Renton, C., Park, A., Bekele, T., Ringash, J., Zhang, H., Burkes, R., Clarke, S., Tannock, I. (2014), Cognitive function and fatigue after diagnosis of colorectal cancer. Annals of Oncology. 25(12), 2404-2412. [Abstract]
  • Linton, A., Pavlakis, N., O'Connell, R., Soeberg, M., Kao, S., Clarke, S., Vardy, J., van Zandwijk, N. (2014), Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales. British Journal of Cancer. 111(9), 1860-1869. [Abstract]
  • Goldstein, D., Bell, M., Butow, P., Sze, M., Vaccaro, L., Dong, S., Liauw, W., Hui, R., Tattersall, M., Ng, W., Asghari, R., Steer, C., Vardy, J., Parente, P., Harris, M., Karanth, N., King, M., Girgis, A., Eisenbruch, M., Jefford, M. (2014), Immigrants' perceptions of the quality of their cancer care - An Australian comparative study, identifying potentially modifiable factors. Annals of Oncology. 25(8), 1643-1649. [Abstract]
  • Vardy, J., Agar, M. (2014), Nonopioid Drugs in the Treatment of Cancer Pain. Journal of Clinical Oncology. 32(16), 1677-1690. [Abstract]
  • Sonpavde, G., Pond, G., Armstrong, A., Clarke, S., Vardy, J., Templeton, A., Wang, S., Paolini, J., Chen, I., Chow-Maneval, E., Lechuga, M., Smith, M., Michaelson, M. (2014), Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 12(5), 317-324. [Abstract]
  • Selamat, M., Loh, S., Mackenzie, L., Vardy, J. (2014), Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications. PloS One. 9(9), e108002. [Abstract]


  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013), Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling. 91(1), 25-28. [Abstract]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013), Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus. 2(1), 126. [Abstract]
  • Linton, A., Kao, S., Vardy, J., Clarke, S., van Zandwijk, N., Klebe, S. (2013), Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review. Asia-Pacific Journal of Clinical Oncology. 9(3), 273-279. [Abstract]
  • Kao, S., Lee, K., Klebe, S., Henderson, D., McCaughan, B., Vardy, J., Clarke, S., van Zandwijk, N. (2013), Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma. Clinical Lung Cancer. 14(2), 164-171. [Abstract]
  • Kao, S., Vardy, J., Harvie, R., Chatfield, M., van Zandwijk, N., Clarke, S., Pavlakis, N. (2013), Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer. 21(3), 697-705. [Abstract]
  • Kao, S., Clarke, S., Vardy, J., Corte, P., Clarke, C., van Zandwijk, N. (2013), Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales of Australia. Internal Medicine Journal. 43(4), 402-410. [Abstract]
  • Linton, A., Pond, G., Clarke, S., Vardy, J., Galsky, M., Sonpavde, G. (2013), Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Clinical Genitourinary Cancer. 11(4), 423-430. [Abstract]
  • Kao, S., Vardy, J., Chatfield, M., Corte, P., Pavlakis, N., Clarke, C., van Zandwijk, N., Clarke, S. (2013), Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data From Patients Seeking Compensation From the New South Wales Dust Diseases Board. Clinical Lung Cancer. 14(1), 70-77. [Abstract]
  • Fardell, J., Vardy, J., Johnston, I. (2013), The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory. Life Sciences. 93(17), 596-604. [Abstract]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Tanious, M., Dong, S., Iedema, R., Vardy, J., Hui, R., Boyle, F., Liauw, W., Goldstein, D. (2013), Should culture affect practice? a comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling. 92(2), 246-252. [Abstract]
  • Kao, S., van Zandwijk, N., Corte, P., Clarke, C., Clarke, S., Vardy, J. (2013), Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma. Supportive Care in Cancer. 21(7), 1879-1884. [Abstract]
  • Burnett, L., Dhillon, H., Vardy, J. (2013), Knowledge and Attitudes of Oncologists about Complementary and Alternative Therapies Used by Cancer Patients. Austral Asian Journal of Cancer. 12(4), 229-238.


  • Vardy, J., Pond, G., Dodd, A., Warr, D., Seruga, B., Clemons, M., Bordeleau, L., Goodwin, P., Tannock, I. (2012), A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 136(1), 143-151. [Abstract]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012), Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Supportive Care in Cancer. 20(6), 1235-1242. [Abstract]
  • Clarey, J., Kao, S., Clarke, S., Vardy, J. (2012), The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials. Annals of Oncology. 23(5), 1229-1233. [Abstract]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012), Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology. 21(5), 496-504. [Abstract]
  • Linton, A., Vardy, J., Clarke, S., van Zandwijk, N. (2012), The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology/Hematology. 84(2), 200-212. [Abstract]
  • Fardell, J., Vardy, J., Shah, J., Johnston, I. (2012), Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology. 220(1), 183-193. [Abstract]
  • Sharpe, M., Fardell, J., Vardy, J., Johnston, I. (2012), The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behavioural Brain Research. 227(1), 295-299. [Abstract]
  • Ahles, T., Schagen, S., Vardy, J. (2012), Neurocognitive Effects of Anticancer Treatments. In: Clinical Psycho-Oncology: An International Perspective. (pp.71-82).United Kingdom: Wiley-Blackwell Publishing.
  • Dhillon, H., van der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012), The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer. 12, 572. [Abstract]


  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology. 6(11), 1923-1929. [Abstract]
  • Fardell, J., Vardy, J., Johnston, I., Winocur, G. (2011), Chemotherapy and Cognitive Impairment: Treatment Options. Clinical pharmacology and therapeutics. 90(3), 366-76. [Abstract]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Tanious, M., Dong, S., Iedema, R., Vardy, J., Ashgari, R., Hui, R., Eisenbruch, M. (2011), Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(20), 2801-7. [Abstract]
  • Wefel, J., Vardy, J., Ahles, T., Schagen, S. (2011), International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology. 12(7), 703-708. [Abstract]
  • Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 43(4), 313-7. [Abstract]
  • Kao, S., Yan, T., Lee, K., Burn, J., Henderson, D., Klebe, S., Kennedy, C., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(3), 602-605. [Abstract]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology. 43(2), 128-132. [Abstract]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011), Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC cancer. 11(1), 142. [Abstract]
  • Vardy, J., Dhillon, H. (2011), Cognitive Function in Cancer Survivors. In: Supportive Oncology. (pp.448-454).United States: Elsevier.


  • Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010), High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research. 16(23), 5805-5813. [Abstract]
  • Fardell, J., Vardy, J., Logge, W., Johnston, I. (2010), Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacology, biochemistry, and behavior. 97(2), 333-9. [Abstract]
  • Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010), Malignant Mesothelioma. Internal Medicine Journal. 40(11), 742-750. [Abstract]
  • Vardy, J., Dhillon, H. (2010), The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast cancer research and treatment. 123(1), 35-7. [Abstract]
  • Kao, S., Butow, P., Bray, V., Clarke, S., Vardy, J. (2010), Patient and oncologist estimates of survival in advanced cancer patients. Psycho-Oncology. 0, 0.
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010), Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. Journal of the Society for Integrative Oncology. 8(2), 56-64. [Abstract]


  • Kao, S., Shafiq, J., Vardy, J., Adams, D. (2009), Use of chemotherapy at end of life in oncology patients. Annals of Oncology. 20(9), 1555-1559. [Abstract]
  • Lai, J., Butt, Z., Wagner, L., Sweet, J., Beaumont, J., Vardy, J., Jacobsen, P., Shapiro, P., Jacobs, S., Cella, D. (2009), Evaluating the dimensionality of perceived cognitive function. Journal of Pain and Symptom Management. 37(6), 982-995. [Abstract]
  • Pollard, A., Eakin, E., Vardy, J., Hawkes, A. (2009), Health behaviour interventions for cancer survivors: An overview of the evidence and contemporary Australian trials. CancerForum. 33(3), 56-64.
  • Vardy, J. (2009), Cognitive function in breast cancer survivors. In: Adjuvant Therapy for Breast Cancer. (pp.387-419).United States: Springer.
  • Vardy, J. (2009), Cognitive function in survivors of cancer. American Society of Clinical Oncology 2009 Education Book. 1, 570-574.
  • Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009), Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC cancer. 9(1), 130. [Abstract]